Leaflet: information for the user
Cefalexina Reiwa Healthcare 500 mg hard capsules EFG
cefalexina
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the leaflet
5 Conservation of Cefalexina Reiwa Healthcare
Cefalexina is an antibiotic. It belongs to a group of antibiotics called cephalosporins.
Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold. It is essential to follow the instructions regarding dosage, administration interval, and treatment duration indicated by your doctor. Do not store or reuse this medication. If you have any leftover antibiotic after finishing the treatment, return it to the pharmacy for proper disposal. Do not throw away medications down the drain or in the trash. |
Cefalexina works by eliminating certain types of bacteria that can cause various types of infections in people. Like all antibiotics, cefalexina is only capable of eliminating certain types of bacteria, so it is only suitable for treating certain types of infections.
Cefalexina can be used to treat the following infections:
Do not take Cefalexina Reiwa Healthcare
Warnings and precautions
Consult your doctor or pharmacist before starting to take Cefalexina Reiwa Healthcare:
Acute generalized exanthematous pustulosis (AGEP) has been reported with the use of cefalexina. AGEP appears at the start of treatment as a red, scaly, and generalized rash with bumps under the skin and blisters accompanied by fever. The most common location is mainly in skin folds, trunk, and upper limbs. The highest risk of this severe skin reaction occurs during the first week of treatment. If you develop a severe rash or any of these skin symptoms, stop taking cefalexina and contact your doctor or seek immediate medical attention.
Other medications and Cefalexina Reiwa Healthcare
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication, including medications obtained without a prescription. This is because they may interact with cefalexina.
In particular, consult your doctor or pharmacist if you are using any of the following medications:
Effects on laboratory tests
Tell your doctor if you are taking Cefalexina Reiwa Healthcare and are undergoing blood or urine tests, as cefalexina may interfere with the results of these tests.
Use of Cefalexina Reiwa Healthcare with food and beverages
Cefalexina Reiwa Healthcare can be taken with a full or empty stomach.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication. Ask your doctor or pharmacist for advice before taking any medication.
Driving and using machines
Cefalexina Reiwa Healthcare may cause dizziness, agitation, hallucinations, or confusion, so you should be cautious when driving or operating machines.
Cefalexina Reiwa Healthcare contains Allura Red (E129)
This medication may cause allergic reactions because it contains Allura Red (E129). It can cause asthma, especially in patients allergic to acetylsalicylic acid.
Follow the administration instructions of this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Dose
Use in adults (≥ 18 years):
The usual dose ranges from 1 to 4 g per day in divided doses, and most infections respond to a dose of 500 mg every 8 hours.
For some infections, such as skin and underlying tissue infections, sore throat, and cystitis, the recommended dose is 250 mg, if available, every 6 hours or 500 mg every 12 hours. If you have a more severe infection, you may need a higher dose.
Use in children (<18 years)
Cefalexina Reiwa Healthcare 500 mg hard capsules are not suitable for the recommended dosing regimens in the pediatric population.
Use in patients with renal insufficiency
If you have severe kidney problems (glomerular filtration rate <10ml/min), a dose reduction is necessary.
Use in elderly patients
The recommended dose is the same as for adults. However, for patients with renal insufficiency, a lower dose may be necessary.
If you take more Cefalexina Reiwa Healthcare than you should
If you have taken more capsules than you should have or if someone else has swallowed some of your capsules, contact your doctor, pharmacist, or the hospital emergency department immediately. Symptoms of overdose may include nausea, vomiting, abdominal pain, diarrhea, and blood in the urine.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Cefalexina Reiwa Healthcare
If you forget to take a dose, take it as soon as you remember. However, if you are due to take another dose soon, skip the missed dose and continue your treatment as before.
Do not take a double dose to make up for missed doses.
If you stop taking Cefalexina Reiwa Healthcare
Use all the capsules that your doctor has prescribed. Do not stop taking them, even if you feel better.
Method of administration
Cefalexina Reiwa Healthcare is administered orally. The capsules should be swallowed whole with a full glass of water.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
If you think you are experiencing any of the following serious side effects, stop taking this medication and inform your doctor immediately or go to the nearest hospital emergency department:
The following side effects have also been reported:
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Frequency not known(frequency cannot be estimated from available data)
If you experience any side effect, talk to your doctor or pharmacist. This includes any possible side effect not listed in this leaflet.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date, which appears on the blister pack and carton after "EXP". The expiration date is the last day of the month indicated.
Store in the original packaging. Keep the blister pack in the outer packaging to protect it from light.
Do not use this medication if you notice visible signs of deterioration.
Medications should not be thrown away down the drain or in the trash. Deposit the packaging and medications you no longer need in the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Cefalexina Reiwa Healthcare
Capsule shell: gelatin, titanium dioxide (E171), potassium and aluminum silicate (E555), brilliant blue FCF (E133), Allura Red (E129).
Printing ink: shellac, potassium hydroxide, black iron oxide (E172).
Appearance of the product and package contents
Cefalexina Reiwa Healthcare is presented in hard gelatin capsules, with the body and cap of the capsule opaque, light blue and dark blue in color, respectively, and with the symbol.
Cefalexina Reiwa Healthcare is available in packages of 28 hard capsules, presented in blister packs (4 blister packs with 7 hard capsules per blister pack).
Marketing authorization holder
Reiwa Healthcare S.L.
Fuencarral Road, 22,
28108 Alcobendas (Madrid),
Spain
Manufacturer
Netpharmalab Consulting Services S.L.
Fuencarral Road, 22,
28108 Alcobendas (Madrid),
Spain
This medication is authorized in the member states of the European Economic Area under the following names:
Germany Cefalexin Reiwa Healthcare 500 mg Hartkapseln
Hungary Cefalexin Reiwa Healthcare 500 mg Kemény kapszula
Date of the last revision of this leaflet:April 2020
Other sources of information
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)